Beyond physiologic sources, pharmacologic 1 C supplementation—including intravenous formate and oral methanol as a formate pro-drug (with deuterated variants for kinetic control)—raises circulating formate and synergizes with anti–PD-1, markedly increasing the durability of tumor regressions in MC38 and other models [52]. The gene discussed is PDCD1; the disease is neoplasm.